MCM2 is involved in subtyping and tamoxifen resistance of ERα‐positive breast cancer by acting as the downstream factor of ERα
Article in Biotechnology Journal (February 2024)
The most recent citing publications are shown below. View all 150 publications that cite this research output on Dimensions.
Article in Biotechnology Journal (February 2024)
Article in Life (December 2023)
Article in Annals of Oncology (October 2023)